Gliatilin, 400mg capsules, 14pcs

Composition

Active ingredient:

choline alfoscerate 400 mg;

Auxiliary substances:

 purified water;

glycerin;

Capsule shell:

gelatin;

ezitol;

sorbitans

;sodium

ethyl parahydroxybenzoate; sodium propyl parahydroxybenzoate;

titanium dioxide (E171);

iron (III) metahydroxide (E172)

Indications

• acute period of TBI mainly stem from the level of the lesion (impaired consciousness, coma, focal poliserna symptoms, symptoms of lesions of the brain stem);
• ischemic (acute and recovery period) and hemorrhagic stroke (recovery period);
• degenerative and involutional psychoorganic syndromes and consequences of cerebrovascular insufficiency such as primary and secondary disorders of mental functions, characterized by memory impairment, confusion, disorientation, decreased motivation, initiative, ability to concentrate;
• changes in emotional and behavioral sphere: emotional lability, increased irritability, loss of interest, senile pseudomeningocele;
• multi-infarct dementia.

Contraindications

Hypersensitivity to the components of the drug.

Side effects

Nausea (as a consequence of dopaminergic activation), in this case, the dose of the drug should be reduced.

Possible allergic reactions.

Interaction

The drug interaction of Gliatilin has not been established.

How to take, course of use and dosage

Inside, before the meal.

For chronic cerebrovascular insufficiency, changes in the emotional and behavioral sphere, and multi-infarction dementia: inside-400 mg (1 capsule) 3 times a day.

The duration of therapy is 3-6 months.

Overdose

Symptoms:  nausea.

If this symptom occurs, it is recommended to reduce the dose of the drug.

Special instructions

In experimental studies, no mutagenic effect of the drug has been established.

– Influence on the ability to drive vehicles and manage mechanisms Gliatilin does not affect the patient’s ability to engage in potentially dangerous activities.

Form of production

Capsules

Storage conditions

At a temperature not exceeding 25 °C

Shelf life

3 years

Active ingredient

Choline alfoscerate

Conditions of release from pharmacies

By prescription

Dosage form

Capsules

Description

For adults as directed by your doctor

Indications

Consequences of Stroke, Acquired Dementia, Mental disorders, Alzheimer ‘s Disease